Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 2
2021 1
2022 4
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy.
Epperly R, Li Y, Selukar S, Zeng E, Madden R, Mamcarz E, Naik S, Qudeimat A, Sharma A, Talleur A, Dallas MH, Gottschalk S, Srinivasan A, Triplett B. Epperly R, et al. Transplant Cell Ther. 2024 May;30(5):526.e1-526.e11. doi: 10.1016/j.jtct.2024.02.016. Epub 2024 Feb 20. Transplant Cell Ther. 2024. PMID: 38387720 Free article.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia.
Petgrave YP, Selukar S, Epperly R, Naik S, Santos ND, Triplett BM, Gottschalk S, Bissler J, Talleur AC. Petgrave YP, et al. Among authors: epperly r. Res Sq [Preprint]. 2023 Oct 6:rs.3.rs-3396661. doi: 10.21203/rs.3.rs-3396661/v1. Res Sq. 2023. PMID: 37886451 Free PMC article. Updated. Preprint.
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells.
Epperly R, Giordani VM, Mikkilineni L, Shah NN. Epperly R, et al. Hematol Oncol Clin North Am. 2023 Dec;37(6):1169-1188. doi: 10.1016/j.hoc.2023.05.010. Epub 2023 Jun 21. Hematol Oncol Clin North Am. 2023. PMID: 37349152 Review.
Outcomes following intolerance to calcineurin inhibitor-based graft-versus-host disease prophylaxis in children after allogeneic hematopoietic cell transplantation.
Wu D, Li Y, Bi Y, Lannom TM, Ward DA, Qudeimat A, Madden RM, Sharma A, Epperly R, Mamcarz E, Talleur A, Naik S, Selukar S, Triplett B, Srinivasan A. Wu D, et al. Among authors: epperly r. Pediatr Blood Cancer. 2023 Jun 20:e30517. doi: 10.1002/pbc.30517. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37338275
20 results